Calluna Pharma

Calluna Pharma develops novel therapies leveraging the body's immune system to treat inflammatory and fibrotic diseases. Their approach involves precision targeting of innate immune amplifiers, resulting in a pipeline of selective antibodies for various immunological diseases.


Buy Funded Startups lists

Funding Round: Series A

Funding Amount: €75M

Date: 23-Jan-2024

Investors: Forbion, Sarsia, p53, Investinor

Markets: Biotechnology, Pharmaceuticals, Immunology, Drug Discovery, HealthTech, Life Sciences

HQ: Oslo, Oslo, Norway

Founded: 2024

Website: https://www.callunapharma.com

LinkedIn: https://www.linkedin.com/company/callunapharma/

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/calluna-pharma

Pitchbook: https://pitchbook.com/profiles/company/554072-68


Leave a Comment